Stage-Specific Inhibition of MHC Class I Presentation by the Epstein-Barr Virus BNLF2a Protein during Virus Lytic Cycle
暂无分享,去创建一个
E. Kremmer | M. Ressing | N. Croft | M. Rowe | A. Rickinson | Jaap M Middeldorp | E. Wiertz | D. Horst | A. Hislop | C. Shannon-Lowe | A. Bell
[1] M. Ressing,et al. The Epstein-Barr Virus G-Protein-Coupled Receptor Contributes to Immune Evasion by Targeting MHC Class I Molecules for Degradation , 2009, PLoS pathogens.
[2] P. Deegen,et al. The Immune Evasion Paradox: Immunoevasins of Murine Cytomegalovirus Enhance Priming of CD8 T Cells by Preventing Negative Feedback Regulation , 2008, Journal of Virology.
[3] M. Ressing,et al. The DNase of Gammaherpesviruses Impairs Recognition by Virus-Specific CD8+ T Cells through an Additional Host Shutoff Function , 2007, Journal of Virology.
[4] M. Ressing,et al. A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates , 2007, The Journal of experimental medicine.
[5] M. Munks,et al. Viral Interference with Antigen Presentation Does Not Alter Acute or Chronic CD8 T Cell Immunodominance in Murine Cytomegalovirus Infection1 , 2007, The Journal of Immunology.
[6] M. Ressing,et al. Host shutoff during productive Epstein–Barr virus infection is mediated by BGLF5 and may contribute to immune evasion , 2007, Proceedings of the National Academy of Sciences.
[7] J. Yewdell,et al. The DRiP hypothesis decennial: support, controversy, refinement and extension. , 2006, Trends in immunology.
[8] E. Kieff,et al. Virus and Cell RNAs Expressed during Epstein-Barr Virus Replication , 2006, Journal of Virology.
[9] J. Neefjes,et al. MHC class I alleles and their exploration of the antigen‐processing machinery , 2005, Immunological reviews.
[10] H. Ploegh,et al. Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond , 2005, Immunological reviews.
[11] M. Ressing,et al. Impaired Transporter Associated with Antigen Processing-Dependent Peptide Transport during Productive EBV Infection1 , 2005, The Journal of Immunology.
[12] A. Rickinson,et al. CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells , 2005, The Journal of experimental medicine.
[13] U. Koszinowski,et al. Murine Cytomegalovirus Interference with Antigen Presentation Has Little Effect on the Size or the Effector Memory Phenotype of the CD8 T Cell Response1 , 2004, The Journal of Immunology.
[14] K. Früh,et al. Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. , 2004, Immunity.
[15] G. Griffiths,et al. The role of the secretory immunological synapse in killing by CD8+ CTL. , 2003, Seminars in immunology.
[16] E. Wiertz,et al. Viral immune evasion: a masterpiece of evolution , 2002, Immunogenetics.
[17] M. Rowe,et al. The Lytic Cycle of Epstein-Barr Virus Is Associated with Decreased Expression of Cell Surface Major Histocompatibility Complex Class I and Class II Molecules , 2002, Journal of Virology.
[18] U. Koszinowski,et al. K3-mediated evasion of CD8+ T cells aids amplification of a latent γ-herpesvirus , 2002, Nature Immunology.
[19] A. Rickinson,et al. Epitope-specific Evolution of Human CD8+ T Cell Responses from Primary to Persistent Phases of Epstein-Barr Virus Infection , 2002, The Journal of experimental medicine.
[20] P. Rivailler,et al. Complete Nucleotide Sequence of the Rhesus Lymphocryptovirus: Genetic Validation for an Epstein-Barr Virus Animal Model , 2002, Journal of Virology.
[21] U. Koszinowski,et al. K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus. , 2002, Nature immunology.
[22] A. Rickinson,et al. Processing of a Multiple Membrane Spanning Epstein-Barr Virus Protein for Cd8+T Cell Recognition Reveals a Proteasome-Dependent, Transporter Associated with Antigen Processing–Independent Pathway , 2001, The Journal of experimental medicine.
[23] M. Bonneville,et al. A global appraisal of immunodominant CD8 T cell responses to Epstein‐Barr virus and cytomegalovirus by bulk screening , 2000, European journal of immunology.
[24] W. Hammerschmidt,et al. The Epstein–Barr virus lytic program is controlled by the co‐operative functions of two transactivators , 2000, The EMBO journal.
[25] W. Hammerschmidt,et al. Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[26] J. Nicholls,et al. Epstein‐Barr virus expression within keratinizing nasopharyngeal carcinoma , 1998, Journal of medical virology.
[27] Jaap M Middeldorp,et al. A major DNA binding protein encoded by BALF2 open reading frame of Epstein-Barr virus (EBV) forms a complex with other EBV DNA-binding proteins: DNAase, EA-D, and DNA polymerase. , 1997, Virology.
[28] A. Kumar,et al. Immediate Early and Early Lytic Cycle Proteins Are Frequent Targets of the Epstein-Barr Virus–induced Cytotoxic T Cell Response , 1997, The Journal of experimental medicine.
[29] M. Bonneville,et al. T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis , 1996, The Journal of experimental medicine.
[30] H. Ploegh,et al. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[31] B. Biegalke. Regulation of human cytomegalovirus US3 gene transcription by a cis-repressive sequence , 1995, Journal of virology.
[32] S. Modrow,et al. Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus , 1995, Journal of virology.
[33] E. van Heerde,et al. Gene mapping and expression of two immunodominant Epstein-Barr virus capsid proteins , 1993, Journal of virology.
[34] D. Tenney,et al. Human cytomegalovirus UL36-38 and US3 immediate-early genes: temporally regulated expression of nuclear, cytoplasmic, and polysome-associated transcripts during infection , 1991, Journal of virology.
[35] G. Packham,et al. Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia , 1991, Journal of virology.
[36] U. Nater,et al. Epstein-Barr virus. , 1991, The Journal of family practice.
[37] T. Jones,et al. Fine mapping of transcripts expressed from the US6 gene family of human cytomegalovirus strain AD169 , 1991, Journal of virology.
[38] M. Buisson,et al. The Epstein-Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and R , 1989, Journal of virology.
[39] E. Kieff,et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. , 1989, The New England journal of medicine.
[40] K. Takada,et al. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes , 1989, Journal of virology.
[41] J. Poduslo,et al. Production of monoclonal antibody to a late intracellular Epstein-Barr virus-induced antigen. , 1984, Virology.